Drug Shortage Report for MAR-GALANTAMINE ER

Last updated on 2021-10-26 History
Report ID 894
Drug Identification Number 02420848
Brand name MAR-GALANTAMINE ER
Common or Proper name MAR-Galantamine
Company Name MARCAN PHARMACEUTICALS INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GALANTAMINE
Strength(s) 16MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 30 Capsule
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-03-13
Actual start date 2017-04-01
Estimated end date Unknown
Actual end date 2017-04-01
Shortage status Resolved
Updated date 2021-10-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-10-26 French Compare
v10 2021-10-26 English Compare
v9 2018-07-06 French Compare
v8 2018-07-06 English Compare
v7 2018-04-02 French Compare
v6 2018-04-02 English Compare
v5 2017-11-23 French Compare
v4 2017-11-23 English Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 11 of 11